| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 29 | 2024 | 373 | 5.080 |
Why?
|
| Lung | 46 | 2026 | 4106 | 3.030 |
Why?
|
| Macrophages | 28 | 2026 | 1507 | 2.780 |
Why?
|
| Acute Lung Injury | 10 | 2018 | 305 | 2.280 |
Why?
|
| Pneumonia | 17 | 2024 | 636 | 1.810 |
Why?
|
| Apoptosis | 24 | 2025 | 2440 | 1.710 |
Why?
|
| Pulmonary Fibrosis | 7 | 2024 | 395 | 1.640 |
Why?
|
| Lung Injury | 4 | 2024 | 244 | 1.570 |
Why?
|
| Inflammation | 18 | 2023 | 2878 | 1.510 |
Why?
|
| Phagocytosis | 16 | 2023 | 296 | 1.480 |
Why?
|
| Bleomycin | 7 | 2024 | 255 | 1.270 |
Why?
|
| Sequence Analysis, RNA | 6 | 2023 | 442 | 1.250 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2024 | 574 | 1.250 |
Why?
|
| Cigarette Smoking | 2 | 2022 | 102 | 1.210 |
Why?
|
| Pulmonary Alveoli | 7 | 2024 | 385 | 1.210 |
Why?
|
| Mice, Inbred C57BL | 44 | 2025 | 5983 | 1.210 |
Why?
|
| Bronchoalveolar Lavage Fluid | 10 | 2026 | 638 | 1.180 |
Why?
|
| Mice | 71 | 2026 | 18329 | 1.120 |
Why?
|
| Pulmonary Emphysema | 3 | 2024 | 277 | 1.100 |
Why?
|
| Animals | 91 | 2026 | 38030 | 1.070 |
Why?
|
| Myeloid Cells | 3 | 2019 | 147 | 0.970 |
Why?
|
| Toll-Like Receptors | 1 | 2026 | 193 | 0.880 |
Why?
|
| Membrane Glycoproteins | 4 | 2024 | 499 | 0.860 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 7 | 2024 | 919 | 0.860 |
Why?
|
| Alternative Splicing | 2 | 2026 | 247 | 0.840 |
Why?
|
| Lipopolysaccharides | 12 | 2024 | 858 | 0.840 |
Why?
|
| Mucins | 4 | 2025 | 75 | 0.820 |
Why?
|
| Mice, Transgenic | 19 | 2023 | 2188 | 0.810 |
Why?
|
| Phagocytes | 5 | 2020 | 80 | 0.810 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 5 | 2024 | 692 | 0.790 |
Why?
|
| Gene Expression Profiling | 9 | 2025 | 1767 | 0.780 |
Why?
|
| Disease Models, Animal | 18 | 2025 | 4560 | 0.770 |
Why?
|
| Monocytes | 9 | 2023 | 539 | 0.750 |
Why?
|
| RNA Splicing | 3 | 2023 | 284 | 0.720 |
Why?
|
| Dyspnea | 7 | 2015 | 250 | 0.720 |
Why?
|
| Cytophagocytosis | 1 | 2022 | 5 | 0.710 |
Why?
|
| RNA Precursors | 2 | 2020 | 154 | 0.710 |
Why?
|
| Polyamines | 1 | 2022 | 42 | 0.700 |
Why?
|
| Lymph Nodes | 5 | 2020 | 503 | 0.660 |
Why?
|
| Humans | 106 | 2026 | 145474 | 0.610 |
Why?
|
| Mucus | 4 | 2025 | 75 | 0.600 |
Why?
|
| RNA, Messenger | 4 | 2026 | 2803 | 0.580 |
Why?
|
| Superoxide Dismutase | 3 | 2019 | 308 | 0.580 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2016 | 68 | 0.550 |
Why?
|
| Regeneration | 2 | 2024 | 197 | 0.550 |
Why?
|
| Leukocytes | 4 | 2026 | 296 | 0.550 |
Why?
|
| Male | 59 | 2026 | 72842 | 0.540 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2018 | 20 | 0.540 |
Why?
|
| Virus Diseases | 2 | 2018 | 216 | 0.540 |
Why?
|
| CD11 Antigens | 1 | 2018 | 30 | 0.530 |
Why?
|
| Actins | 2 | 2020 | 425 | 0.530 |
Why?
|
| Epithelial Cells | 5 | 2018 | 1131 | 0.520 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2023 | 1217 | 0.520 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2017 | 39 | 0.520 |
Why?
|
| Flow Cytometry | 9 | 2022 | 1162 | 0.520 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 919 | 0.520 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2026 | 119 | 0.510 |
Why?
|
| Antigens, CD | 4 | 2017 | 558 | 0.500 |
Why?
|
| CD11b Antigen | 2 | 2016 | 60 | 0.500 |
Why?
|
| Gene Deletion | 2 | 2018 | 391 | 0.500 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 2016 | 66 | 0.490 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2016 | 22 | 0.490 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 73 | 0.480 |
Why?
|
| Mice, Knockout | 17 | 2025 | 3124 | 0.480 |
Why?
|
| Inflammation Mediators | 5 | 2017 | 506 | 0.470 |
Why?
|
| Diagnosis, Differential | 11 | 2016 | 1508 | 0.470 |
Why?
|
| Receptors, Immunologic | 4 | 2019 | 208 | 0.460 |
Why?
|
| Signal Transduction | 14 | 2026 | 5216 | 0.460 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 231 | 0.450 |
Why?
|
| Teratoma | 1 | 2016 | 124 | 0.450 |
Why?
|
| Female | 51 | 2026 | 78844 | 0.450 |
Why?
|
| Neutrophils | 8 | 2025 | 1124 | 0.450 |
Why?
|
| Podocytes | 3 | 2020 | 80 | 0.440 |
Why?
|
| Lung Diseases | 4 | 2022 | 780 | 0.430 |
Why?
|
| Hypertension, Pulmonary | 7 | 2020 | 1957 | 0.430 |
Why?
|
| Fas Ligand Protein | 1 | 2014 | 61 | 0.420 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 624 | 0.410 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 1 | 2013 | 3 | 0.400 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2013 | 20 | 0.400 |
Why?
|
| Immune System Diseases | 1 | 2013 | 37 | 0.390 |
Why?
|
| Mycobacterium abscessus | 2 | 2026 | 110 | 0.390 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2013 | 161 | 0.380 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 192 | 0.380 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2019 | 140 | 0.370 |
Why?
|
| Muscle Weakness | 1 | 2013 | 92 | 0.370 |
Why?
|
| Single-Cell Analysis | 3 | 2024 | 362 | 0.370 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 33 | 0.370 |
Why?
|
| fas Receptor | 2 | 2014 | 91 | 0.360 |
Why?
|
| Mucin 5AC | 5 | 2025 | 71 | 0.360 |
Why?
|
| Bone Marrow Transplantation | 4 | 2015 | 298 | 0.350 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2013 | 122 | 0.350 |
Why?
|
| Sepsis | 1 | 2018 | 664 | 0.350 |
Why?
|
| Cough | 4 | 2015 | 124 | 0.340 |
Why?
|
| Asthma | 7 | 2025 | 1797 | 0.340 |
Why?
|
| Severity of Illness Index | 5 | 2025 | 2930 | 0.330 |
Why?
|
| Alveolar Epithelial Cells | 2 | 2024 | 121 | 0.330 |
Why?
|
| Healthy Volunteers | 2 | 2022 | 219 | 0.320 |
Why?
|
| Transforming Growth Factor beta | 5 | 2017 | 474 | 0.320 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 595 | 0.320 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2025 | 104 | 0.320 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 2 | 2026 | 339 | 0.320 |
Why?
|
| Zinc | 1 | 2013 | 306 | 0.320 |
Why?
|
| Macrophage Activation | 3 | 2022 | 181 | 0.310 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2010 | 20 | 0.310 |
Why?
|
| Middle Aged | 22 | 2026 | 36215 | 0.310 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 435 | 0.310 |
Why?
|
| Gamma Rays | 1 | 2010 | 57 | 0.310 |
Why?
|
| Whole-Body Irradiation | 1 | 2010 | 74 | 0.300 |
Why?
|
| Hypoxia | 5 | 2022 | 1199 | 0.300 |
Why?
|
| Kidney Glomerulus | 2 | 2020 | 125 | 0.300 |
Why?
|
| Mucociliary Clearance | 3 | 2018 | 44 | 0.290 |
Why?
|
| Thrombospondin 1 | 2 | 2020 | 28 | 0.290 |
Why?
|
| Cells, Cultured | 16 | 2019 | 4148 | 0.290 |
Why?
|
| Respiratory Mucosa | 5 | 2025 | 322 | 0.290 |
Why?
|
| Thyrotoxicosis | 1 | 2008 | 7 | 0.290 |
Why?
|
| Antigens, Differentiation | 2 | 2008 | 76 | 0.280 |
Why?
|
| Liver Failure, Acute | 1 | 2009 | 68 | 0.280 |
Why?
|
| Cytokines | 9 | 2023 | 2067 | 0.280 |
Why?
|
| Fibrosis | 4 | 2024 | 559 | 0.280 |
Why?
|
| Lymphomatoid Granulomatosis | 1 | 2008 | 5 | 0.280 |
Why?
|
| Herpes Simplex | 1 | 2009 | 99 | 0.280 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2008 | 31 | 0.270 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2008 | 30 | 0.270 |
Why?
|
| Influenza, Human | 2 | 2024 | 624 | 0.270 |
Why?
|
| Chest Pain | 1 | 2008 | 99 | 0.270 |
Why?
|
| Pharyngitis | 1 | 2008 | 25 | 0.270 |
Why?
|
| Mucin-5B | 4 | 2025 | 234 | 0.250 |
Why?
|
| Cell Count | 2 | 2020 | 319 | 0.240 |
Why?
|
| Interleukin-6 | 6 | 2023 | 776 | 0.240 |
Why?
|
| Alcoholism | 1 | 2013 | 822 | 0.240 |
Why?
|
| Tracheitis | 1 | 2006 | 3 | 0.240 |
Why?
|
| Tobramycin | 1 | 2026 | 63 | 0.240 |
Why?
|
| Breeding | 2 | 2018 | 63 | 0.240 |
Why?
|
| Bronchitis | 1 | 2006 | 29 | 0.240 |
Why?
|
| Mitochondria | 2 | 2025 | 992 | 0.240 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2023 | 165 | 0.240 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2026 | 41 | 0.240 |
Why?
|
| Interleukin-13 | 2 | 2018 | 146 | 0.230 |
Why?
|
| Leukocyte Common Antigens | 2 | 2018 | 87 | 0.230 |
Why?
|
| Sleep Apnea, Central | 1 | 2005 | 13 | 0.230 |
Why?
|
| Factor XIII | 1 | 2025 | 15 | 0.230 |
Why?
|
| Cathepsins | 1 | 2025 | 24 | 0.230 |
Why?
|
| Plasminogen | 1 | 2025 | 27 | 0.220 |
Why?
|
| Dendritic Cells | 5 | 2020 | 499 | 0.220 |
Why?
|
| Jaundice | 1 | 2004 | 10 | 0.220 |
Why?
|
| Fucosyltransferases | 1 | 2025 | 33 | 0.220 |
Why?
|
| Methemoglobinemia | 1 | 2004 | 13 | 0.220 |
Why?
|
| Pulmonary Artery | 2 | 2017 | 1127 | 0.220 |
Why?
|
| Vasoconstriction | 2 | 2020 | 216 | 0.210 |
Why?
|
| Chemokine CXCL12 | 1 | 2025 | 86 | 0.210 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2024 | 89 | 0.210 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2004 | 34 | 0.210 |
Why?
|
| Immunohistochemistry | 5 | 2020 | 1716 | 0.210 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2025 | 118 | 0.210 |
Why?
|
| Eye Proteins | 1 | 2024 | 92 | 0.210 |
Why?
|
| Influenza A virus | 2 | 2018 | 119 | 0.210 |
Why?
|
| Colitis, Ulcerative | 1 | 2006 | 148 | 0.210 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 71 | 0.200 |
Why?
|
| Lactation | 1 | 2025 | 193 | 0.200 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 2016 | 49 | 0.200 |
Why?
|
| Gene Expression | 3 | 2018 | 1476 | 0.200 |
Why?
|
| Fibrinolysis | 1 | 2025 | 164 | 0.200 |
Why?
|
| Transcriptome | 3 | 2022 | 1038 | 0.200 |
Why?
|
| Bone Marrow Cells | 4 | 2017 | 321 | 0.200 |
Why?
|
| Hospitalists | 1 | 2008 | 267 | 0.200 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 1996 | 0.200 |
Why?
|
| Adult | 18 | 2025 | 40777 | 0.200 |
Why?
|
| Calcinosis | 1 | 2005 | 234 | 0.200 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 2664 | 0.200 |
Why?
|
| Endothelial Cells | 4 | 2025 | 874 | 0.190 |
Why?
|
| Biliary Atresia | 1 | 2025 | 158 | 0.190 |
Why?
|
| Folate Receptor 2 | 1 | 2023 | 8 | 0.190 |
Why?
|
| Blood Coagulation Disorders | 1 | 2025 | 198 | 0.190 |
Why?
|
| Fibroblasts | 6 | 2017 | 1025 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 7 | 2021 | 1261 | 0.190 |
Why?
|
| Scoliosis | 1 | 2005 | 221 | 0.190 |
Why?
|
| Intensive Care Units | 2 | 2013 | 924 | 0.190 |
Why?
|
| Glucosylceramidase | 1 | 2022 | 5 | 0.190 |
Why?
|
| Vascular System Injuries | 1 | 2023 | 81 | 0.180 |
Why?
|
| Killer Cells, Natural | 2 | 2023 | 480 | 0.180 |
Why?
|
| Peripheral Tolerance | 1 | 2022 | 15 | 0.180 |
Why?
|
| Postpartum Period | 1 | 2025 | 373 | 0.180 |
Why?
|
| X-Ray Microtomography | 1 | 2022 | 108 | 0.180 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 40 | 0.180 |
Why?
|
| Shock, Septic | 2 | 2018 | 227 | 0.180 |
Why?
|
| Spermine | 1 | 2022 | 29 | 0.180 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2022 | 40 | 0.180 |
Why?
|
| Cellular Microenvironment | 2 | 2020 | 93 | 0.180 |
Why?
|
| Spermidine | 1 | 2022 | 18 | 0.180 |
Why?
|
| Gene Expression Regulation | 6 | 2025 | 2597 | 0.180 |
Why?
|
| Neuropeptides | 1 | 2022 | 75 | 0.180 |
Why?
|
| Critical Care | 1 | 2008 | 702 | 0.170 |
Why?
|
| Cell Lineage | 3 | 2020 | 377 | 0.170 |
Why?
|
| NF-kappa B | 3 | 2024 | 666 | 0.170 |
Why?
|
| Glycosylation | 2 | 2025 | 173 | 0.170 |
Why?
|
| Immunoglobulin G | 2 | 2024 | 892 | 0.170 |
Why?
|
| Cysts | 1 | 2022 | 112 | 0.170 |
Why?
|
| Extracellular Traps | 1 | 2021 | 52 | 0.170 |
Why?
|
| Critical Illness | 1 | 2008 | 900 | 0.170 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 686 | 0.170 |
Why?
|
| Repressor Proteins | 1 | 2024 | 429 | 0.170 |
Why?
|
| Sulfhydryl Compounds | 1 | 2023 | 189 | 0.170 |
Why?
|
| Immunomodulation | 1 | 2022 | 99 | 0.160 |
Why?
|
| Disease Progression | 2 | 2024 | 2864 | 0.160 |
Why?
|
| Intermediate Filaments | 1 | 2020 | 25 | 0.160 |
Why?
|
| Aged | 10 | 2024 | 26153 | 0.160 |
Why?
|
| Disulfides | 1 | 2021 | 94 | 0.160 |
Why?
|
| Steroid Hydroxylases | 1 | 2020 | 19 | 0.160 |
Why?
|
| Foreign Bodies | 1 | 2022 | 110 | 0.160 |
Why?
|
| Leukosialin | 1 | 2020 | 12 | 0.160 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 10 | 0.160 |
Why?
|
| Optical Devices | 1 | 2020 | 13 | 0.160 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2021 | 1180 | 0.160 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 1 | 2021 | 127 | 0.160 |
Why?
|
| MicroRNAs | 2 | 2017 | 686 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 296 | 0.160 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 59 | 0.160 |
Why?
|
| Bronchi | 2 | 2015 | 263 | 0.160 |
Why?
|
| Vimentin | 1 | 2020 | 54 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2019 | 162 | 0.150 |
Why?
|
| Pressure | 1 | 2021 | 226 | 0.150 |
Why?
|
| Sputum | 1 | 2021 | 302 | 0.150 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 372 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 2 | 2018 | 181 | 0.150 |
Why?
|
| Oxidative Stress | 4 | 2020 | 1356 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2026 | 967 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 382 | 0.150 |
Why?
|
| Extracellular Fluid | 1 | 2019 | 38 | 0.150 |
Why?
|
| Implants, Experimental | 1 | 2019 | 21 | 0.150 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2017 | 664 | 0.150 |
Why?
|
| Organ Specificity | 3 | 2017 | 309 | 0.150 |
Why?
|
| Blood Vessels | 1 | 2021 | 167 | 0.150 |
Why?
|
| Perfusion | 1 | 2021 | 251 | 0.150 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2019 | 2 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2017 | 2769 | 0.150 |
Why?
|
| Busulfan | 1 | 2019 | 15 | 0.150 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2019 | 14 | 0.150 |
Why?
|
| Gene Targeting | 2 | 2018 | 81 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 1 | 2005 | 599 | 0.150 |
Why?
|
| rho-Associated Kinases | 4 | 2020 | 82 | 0.150 |
Why?
|
| CD3 Complex | 2 | 2018 | 112 | 0.150 |
Why?
|
| Lentivirus | 1 | 2019 | 61 | 0.150 |
Why?
|
| Arginase | 1 | 2019 | 26 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 2 | 2026 | 1923 | 0.140 |
Why?
|
| Vital Capacity | 3 | 2017 | 292 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 174 | 0.140 |
Why?
|
| Dasatinib | 1 | 2019 | 58 | 0.140 |
Why?
|
| Cholestenes | 1 | 2018 | 5 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2020 | 199 | 0.140 |
Why?
|
| Adoptive Transfer | 3 | 2014 | 200 | 0.140 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2019 | 88 | 0.140 |
Why?
|
| Alpha-Globulins | 1 | 2018 | 20 | 0.140 |
Why?
|
| Actin Cytoskeleton | 1 | 2019 | 103 | 0.140 |
Why?
|
| Chemokine CCL11 | 1 | 2018 | 25 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2026 | 1734 | 0.140 |
Why?
|
| Polyethylene Glycols | 2 | 2022 | 649 | 0.140 |
Why?
|
| Viral Plaque Assay | 1 | 2018 | 29 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 372 | 0.130 |
Why?
|
| Interferon-beta | 1 | 2018 | 92 | 0.130 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 45 | 0.130 |
Why?
|
| Hypersensitivity | 1 | 2021 | 254 | 0.130 |
Why?
|
| Genotype | 2 | 2025 | 1852 | 0.130 |
Why?
|
| Transplantation Conditioning | 1 | 2019 | 191 | 0.130 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 71 | 0.130 |
Why?
|
| Genetic Vectors | 1 | 2019 | 335 | 0.130 |
Why?
|
| Lymphocyte Depletion | 1 | 2018 | 132 | 0.130 |
Why?
|
| Biomarkers | 3 | 2024 | 4295 | 0.130 |
Why?
|
| Schistosoma | 1 | 2017 | 28 | 0.130 |
Why?
|
| Integrases | 1 | 2018 | 122 | 0.130 |
Why?
|
| RNA Virus Infections | 1 | 2017 | 19 | 0.120 |
Why?
|
| Myoclonus | 1 | 2016 | 16 | 0.120 |
Why?
|
| Genetic Therapy | 1 | 2019 | 316 | 0.120 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2018 | 81 | 0.120 |
Why?
|
| Endothelium | 2 | 2014 | 119 | 0.120 |
Why?
|
| Hallucinations | 1 | 2016 | 31 | 0.120 |
Why?
|
| Viremia | 1 | 2018 | 160 | 0.120 |
Why?
|
| Tissue Donors | 1 | 2020 | 420 | 0.120 |
Why?
|
| Wounds and Injuries | 1 | 2025 | 961 | 0.120 |
Why?
|
| 5'-Nucleotidase | 1 | 2017 | 49 | 0.120 |
Why?
|
| Recombination, Genetic | 1 | 2018 | 203 | 0.120 |
Why?
|
| Up-Regulation | 4 | 2018 | 847 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3623 | 0.120 |
Why?
|
| Glycoproteins | 2 | 2021 | 354 | 0.120 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2016 | 29 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 1140 | 0.120 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2016 | 116 | 0.120 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2016 | 10 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 317 | 0.120 |
Why?
|
| Oxidants | 2 | 2007 | 99 | 0.120 |
Why?
|
| Transplantation, Homologous | 3 | 2018 | 418 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2020 | 425 | 0.120 |
Why?
|
| Psychomotor Agitation | 1 | 2016 | 69 | 0.120 |
Why?
|
| Blood Donors | 1 | 2018 | 144 | 0.120 |
Why?
|
| Histones | 1 | 2021 | 666 | 0.120 |
Why?
|
| Hydrogels | 2 | 2022 | 701 | 0.120 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 226 | 0.120 |
Why?
|
| Reactive Oxygen Species | 3 | 2009 | 611 | 0.120 |
Why?
|
| Trachea | 2 | 2015 | 258 | 0.120 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 34 | 0.120 |
Why?
|
| Parkinson Disease | 1 | 2022 | 599 | 0.120 |
Why?
|
| Schistosomiasis mansoni | 1 | 2015 | 25 | 0.110 |
Why?
|
| RNA Viruses | 1 | 2017 | 73 | 0.110 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2014 | 25 | 0.110 |
Why?
|
| Radiography | 3 | 2013 | 852 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2012 | 80 | 0.110 |
Why?
|
| Viral Load | 1 | 2018 | 526 | 0.110 |
Why?
|
| Integrins | 1 | 2016 | 90 | 0.110 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2015 | 78 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 4 | 2010 | 76 | 0.110 |
Why?
|
| Carmustine | 1 | 2015 | 52 | 0.110 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 562 | 0.110 |
Why?
|
| Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2014 | 9 | 0.110 |
Why?
|
| Sex Factors | 1 | 2021 | 2105 | 0.110 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1368 | 0.110 |
Why?
|
| Interleukin-4 | 1 | 2015 | 207 | 0.110 |
Why?
|
| rho GTP-Binding Proteins | 3 | 2010 | 56 | 0.110 |
Why?
|
| Acute Kidney Injury | 3 | 2013 | 875 | 0.100 |
Why?
|
| Polysaccharides | 1 | 2014 | 86 | 0.100 |
Why?
|
| Housing, Animal | 1 | 2014 | 46 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2016 | 238 | 0.100 |
Why?
|
| Phenotype | 5 | 2025 | 3155 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2012 | 56 | 0.100 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2014 | 22 | 0.100 |
Why?
|
| AC133 Antigen | 1 | 2013 | 20 | 0.100 |
Why?
|
| Colony-Forming Units Assay | 1 | 2013 | 95 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 361 | 0.100 |
Why?
|
| B-Lymphocytes | 4 | 2022 | 870 | 0.100 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 89 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 86 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1246 | 0.100 |
Why?
|
| Immunoglobulin A | 1 | 2014 | 214 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 3413 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 981 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2012 | 552 | 0.090 |
Why?
|
| Homeostasis | 1 | 2016 | 642 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 41 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 468 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 396 | 0.090 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 450 | 0.090 |
Why?
|
| Glycocalyx | 1 | 2012 | 30 | 0.090 |
Why?
|
| Survivors | 2 | 2013 | 523 | 0.090 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 668 | 0.090 |
Why?
|
| Eosinophils | 1 | 2014 | 316 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2014 | 221 | 0.090 |
Why?
|
| Lymphatic Vessels | 1 | 2012 | 63 | 0.090 |
Why?
|
| Survival Analysis | 5 | 2017 | 1374 | 0.090 |
Why?
|
| Cell Movement | 1 | 2016 | 959 | 0.090 |
Why?
|
| Patient Safety | 1 | 2015 | 356 | 0.090 |
Why?
|
| NADPH Oxidases | 2 | 2009 | 122 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 740 | 0.090 |
Why?
|
| Caspase 8 | 1 | 2011 | 47 | 0.090 |
Why?
|
| Endotoxemia | 1 | 2012 | 86 | 0.090 |
Why?
|
| Metabolomics | 1 | 2017 | 732 | 0.090 |
Why?
|
| Fatal Outcome | 2 | 2009 | 305 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 74 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2019 | 699 | 0.090 |
Why?
|
| Leg | 1 | 2013 | 242 | 0.090 |
Why?
|
| Biopsy | 3 | 2012 | 1082 | 0.080 |
Why?
|
| Hypothalamus | 1 | 2012 | 163 | 0.080 |
Why?
|
| Hypoalbuminemia | 1 | 2010 | 27 | 0.080 |
Why?
|
| Graft vs Host Disease | 2 | 2018 | 279 | 0.080 |
Why?
|
| Radiation Chimera | 1 | 2010 | 28 | 0.080 |
Why?
|
| Allergens | 2 | 2015 | 386 | 0.080 |
Why?
|
| Lymphocytes | 2 | 2014 | 376 | 0.080 |
Why?
|
| Collagen | 1 | 2012 | 457 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 523 | 0.080 |
Why?
|
| Fasting | 1 | 2012 | 279 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 641 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2507 | 0.080 |
Why?
|
| Phosphodiesterase I | 1 | 2009 | 3 | 0.080 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 104 | 0.080 |
Why?
|
| Interferon-gamma | 2 | 2010 | 784 | 0.080 |
Why?
|
| Serotonin Antagonists | 1 | 2009 | 32 | 0.080 |
Why?
|
| Pancreatic Elastase | 1 | 2009 | 53 | 0.080 |
Why?
|
| Herpes Labialis | 1 | 2009 | 9 | 0.070 |
Why?
|
| Photophobia | 1 | 2009 | 13 | 0.070 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 2009 | 61 | 0.070 |
Why?
|
| Herpesvirus 2, Human | 1 | 2009 | 27 | 0.070 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2009 | 40 | 0.070 |
Why?
|
| Adolescent | 5 | 2021 | 22529 | 0.070 |
Why?
|
| Time Factors | 4 | 2018 | 7123 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2009 | 105 | 0.070 |
Why?
|
| Epoprostenol | 1 | 2009 | 132 | 0.070 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2008 | 43 | 0.070 |
Why?
|
| Triiodothyronine | 1 | 2008 | 54 | 0.070 |
Why?
|
| Transcription, Genetic | 4 | 2020 | 1454 | 0.070 |
Why?
|
| Prednisone | 2 | 2008 | 224 | 0.070 |
Why?
|
| RAW 264.7 Cells | 2 | 2020 | 48 | 0.070 |
Why?
|
| Vomiting | 1 | 2009 | 131 | 0.070 |
Why?
|
| Thyroxine | 1 | 2008 | 66 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2011 | 166 | 0.070 |
Why?
|
| Ischemia | 1 | 2011 | 422 | 0.070 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2008 | 65 | 0.070 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2012 | 342 | 0.070 |
Why?
|
| Herpesvirus 1, Human | 1 | 2009 | 84 | 0.070 |
Why?
|
| South Africa | 1 | 2009 | 266 | 0.070 |
Why?
|
| Travel | 1 | 2009 | 136 | 0.070 |
Why?
|
| Hydrogen Peroxide | 2 | 2026 | 335 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2008 | 185 | 0.070 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2008 | 16 | 0.070 |
Why?
|
| Pneumocystis carinii | 1 | 2008 | 12 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2009 | 443 | 0.070 |
Why?
|
| B7-1 Antigen | 1 | 2008 | 55 | 0.070 |
Why?
|
| Tongue | 1 | 2008 | 76 | 0.070 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2008 | 93 | 0.070 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2008 | 34 | 0.070 |
Why?
|
| Pain | 1 | 2013 | 789 | 0.070 |
Why?
|
| Risk Factors | 2 | 2021 | 10885 | 0.070 |
Why?
|
| Peptides | 1 | 2013 | 998 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 2214 | 0.070 |
Why?
|
| Amides | 2 | 2023 | 101 | 0.070 |
Why?
|
| Fever | 1 | 2009 | 319 | 0.070 |
Why?
|
| Ligands | 2 | 2023 | 665 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 2 | 2006 | 307 | 0.070 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 330 | 0.060 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2008 | 47 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2009 | 309 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 848 | 0.060 |
Why?
|
| Phospholipases A | 1 | 2007 | 97 | 0.060 |
Why?
|
| Paragonimiasis | 1 | 2006 | 2 | 0.060 |
Why?
|
| Paragonimus | 1 | 2006 | 2 | 0.060 |
Why?
|
| Smoking | 2 | 2017 | 1472 | 0.060 |
Why?
|
| Species Specificity | 2 | 2020 | 546 | 0.060 |
Why?
|
| Acyl Coenzyme A | 1 | 2006 | 32 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2008 | 440 | 0.060 |
Why?
|
| Cancer Vaccines | 1 | 2008 | 161 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2020 | 276 | 0.060 |
Why?
|
| Lovastatin | 1 | 2006 | 37 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 431 | 0.060 |
Why?
|
| Fluticasone | 1 | 2006 | 53 | 0.060 |
Why?
|
| Androstadienes | 1 | 2006 | 75 | 0.060 |
Why?
|
| Pleural Effusion | 1 | 2006 | 59 | 0.060 |
Why?
|
| Lymphocyte Count | 2 | 2019 | 164 | 0.060 |
Why?
|
| Calreticulin | 1 | 2005 | 22 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2006 | 117 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 333 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 174 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2010 | 892 | 0.060 |
Why?
|
| Respiratory Sounds | 1 | 2006 | 103 | 0.060 |
Why?
|
| Ethanol | 1 | 2010 | 631 | 0.060 |
Why?
|
| Genome, Mitochondrial | 1 | 2025 | 26 | 0.060 |
Why?
|
| Heterozygote | 2 | 2022 | 313 | 0.060 |
Why?
|
| Immunophenotyping | 3 | 2014 | 319 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2008 | 230 | 0.060 |
Why?
|
| Pulmonary Diffusing Capacity | 2 | 2017 | 78 | 0.060 |
Why?
|
| Methemoglobin | 1 | 2004 | 24 | 0.050 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2004 | 11 | 0.050 |
Why?
|
| Uteroglobin | 1 | 2024 | 30 | 0.050 |
Why?
|
| Methylene Blue | 1 | 2004 | 24 | 0.050 |
Why?
|
| Cilia | 2 | 2018 | 173 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2004 | 55 | 0.050 |
Why?
|
| Kupffer Cells | 1 | 2025 | 52 | 0.050 |
Why?
|
| Syndrome | 1 | 2005 | 381 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 978 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2024 | 45 | 0.050 |
Why?
|
| Headache | 1 | 2005 | 151 | 0.050 |
Why?
|
| Cell Separation | 2 | 2019 | 305 | 0.050 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2004 | 70 | 0.050 |
Why?
|
| Jurkat Cells | 3 | 2012 | 115 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2026 | 337 | 0.050 |
Why?
|
| Proteomics | 2 | 2025 | 1188 | 0.050 |
Why?
|
| Thrombelastography | 1 | 2025 | 192 | 0.050 |
Why?
|
| Cysteine | 1 | 2025 | 211 | 0.050 |
Why?
|
| Mice, Inbred ICR | 3 | 2009 | 113 | 0.050 |
Why?
|
| Spine | 1 | 2005 | 182 | 0.050 |
Why?
|
| Kidney | 1 | 2011 | 1497 | 0.050 |
Why?
|
| Zymosan | 1 | 2023 | 39 | 0.050 |
Why?
|
| Splicing Factor U2AF | 1 | 2023 | 18 | 0.050 |
Why?
|
| Quality of Life | 2 | 2013 | 3204 | 0.050 |
Why?
|
| Cell Line | 3 | 2019 | 2823 | 0.050 |
Why?
|
| Exercise Tolerance | 1 | 2005 | 283 | 0.050 |
Why?
|
| Acrylates | 1 | 2023 | 48 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2026 | 395 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2025 | 248 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 178 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 413 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 2 | 2017 | 89 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2019 | 899 | 0.050 |
Why?
|
| Fatigue | 1 | 2005 | 364 | 0.050 |
Why?
|
| Anemia | 1 | 2004 | 191 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2025 | 264 | 0.050 |
Why?
|
| Epithelium | 1 | 2024 | 310 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2023 | 122 | 0.050 |
Why?
|
| Hemolysis | 1 | 2004 | 242 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2023 | 162 | 0.050 |
Why?
|
| Organoids | 1 | 2024 | 145 | 0.050 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2022 | 36 | 0.050 |
Why?
|
| Immunoglobulin D | 1 | 2022 | 29 | 0.050 |
Why?
|
| Th2 Cells | 2 | 2017 | 175 | 0.050 |
Why?
|
| Echocardiography | 1 | 2005 | 647 | 0.050 |
Why?
|
| Receptors, KIR | 1 | 2023 | 118 | 0.050 |
Why?
|
| Ceramides | 1 | 2023 | 117 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 477 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2023 | 312 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2004 | 386 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2009 | 826 | 0.040 |
Why?
|
| Ovalbumin | 2 | 2015 | 194 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 749 | 0.040 |
Why?
|
| Mutation | 2 | 2023 | 4075 | 0.040 |
Why?
|
| Smad2 Protein | 2 | 2015 | 37 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 334 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2020 | 707 | 0.040 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2023 | 189 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 2121 | 0.040 |
Why?
|
| Rats | 4 | 2020 | 5584 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2025 | 534 | 0.040 |
Why?
|
| Fixatives | 1 | 2021 | 13 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 186 | 0.040 |
Why?
|
| Expectorants | 1 | 2021 | 23 | 0.040 |
Why?
|
| Parabiosis | 1 | 2020 | 11 | 0.040 |
Why?
|
| Brain | 1 | 2013 | 2947 | 0.040 |
Why?
|
| United States | 3 | 2019 | 16098 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2020 | 60 | 0.040 |
Why?
|
| Thrombin | 1 | 2021 | 172 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 20 | 0.040 |
Why?
|
| Liver X Receptors | 1 | 2020 | 29 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2020 | 40 | 0.040 |
Why?
|
| Protein Binding | 2 | 2018 | 2238 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2017 | 247 | 0.040 |
Why?
|
| Stem Cells | 1 | 2024 | 628 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 231 | 0.040 |
Why?
|
| Transfection | 2 | 2015 | 926 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2000 | 121 | 0.040 |
Why?
|
| Liver | 2 | 2025 | 1896 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2012 | 762 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2009 | 1371 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 156 | 0.040 |
Why?
|
| Endodeoxyribonucleases | 1 | 2020 | 77 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2014 | 277 | 0.040 |
Why?
|
| Alarmins | 1 | 2019 | 27 | 0.040 |
Why?
|
| Cystic Fibrosis | 2 | 2026 | 1161 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 177 | 0.040 |
Why?
|
| Foreign-Body Reaction | 1 | 2019 | 34 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2023 | 692 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2005 | 1808 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 3 | 2012 | 1505 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2020 | 211 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2019 | 104 | 0.040 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2019 | 81 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 3116 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 208 | 0.030 |
Why?
|
| Roseolovirus Infections | 1 | 2018 | 8 | 0.030 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2019 | 127 | 0.030 |
Why?
|
| Neurons | 2 | 2000 | 1649 | 0.030 |
Why?
|
| Herpesvirus 6, Human | 1 | 2018 | 14 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2009 | 2046 | 0.030 |
Why?
|
| Transplantation, Haploidentical | 1 | 2018 | 23 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2019 | 223 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2019 | 265 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 674 | 0.030 |
Why?
|
| Autophagy | 1 | 2020 | 291 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2022 | 429 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 372 | 0.030 |
Why?
|
| RNA Transport | 1 | 2017 | 27 | 0.030 |
Why?
|
| Respiratory Insufficiency | 2 | 2012 | 326 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 172 | 0.030 |
Why?
|
| Bone Marrow | 2 | 2008 | 306 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2017 | 45 | 0.030 |
Why?
|
| Models, Biological | 3 | 2013 | 1764 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 88 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2014 | 1132 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2017 | 41 | 0.030 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2017 | 44 | 0.030 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2017 | 23 | 0.030 |
Why?
|
| Apyrase | 1 | 2017 | 27 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2017 | 39 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 767 | 0.030 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2017 | 65 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2017 | 93 | 0.030 |
Why?
|
| Rheumatoid Factor | 1 | 2017 | 178 | 0.030 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2015 | 9 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2015 | 24 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2015 | 42 | 0.030 |
Why?
|
| Hematologic Neoplasms | 1 | 2018 | 168 | 0.030 |
Why?
|
| Schistosoma mansoni | 1 | 2015 | 41 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2018 | 11853 | 0.030 |
Why?
|
| Cell Communication | 1 | 2017 | 328 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2018 | 368 | 0.030 |
Why?
|
| Mitotic Index | 1 | 2015 | 25 | 0.030 |
Why?
|
| Auscultation | 1 | 2015 | 4 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 57 | 0.030 |
Why?
|
| Aspergillus oryzae | 1 | 2015 | 4 | 0.030 |
Why?
|
| Child | 4 | 2018 | 22707 | 0.030 |
Why?
|
| Graft Survival | 1 | 2018 | 518 | 0.030 |
Why?
|
| Prognosis | 2 | 2017 | 4316 | 0.030 |
Why?
|
| Mucin-4 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Methacholine Chloride | 1 | 2015 | 51 | 0.030 |
Why?
|
| Adenosine | 1 | 2017 | 255 | 0.030 |
Why?
|
| DNA | 1 | 2021 | 1435 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2015 | 139 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 311 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2022 | 1509 | 0.030 |
Why?
|
| Cattle | 1 | 2017 | 946 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2014 | 22 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2015 | 101 | 0.030 |
Why?
|
| Interleukin-27 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2014 | 30 | 0.030 |
Why?
|
| Poly I-C | 1 | 2014 | 58 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2014 | 43 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 2014 | 18 | 0.030 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 12 | 0.030 |
Why?
|
| Lung Compliance | 1 | 2014 | 42 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2014 | 42 | 0.030 |
Why?
|
| RNA | 1 | 2020 | 910 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 310 | 0.030 |
Why?
|
| Infant | 2 | 2019 | 10077 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 55 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 376 | 0.030 |
Why?
|
| Somatosensory Cortex | 1 | 1994 | 42 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2015 | 172 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 146 | 0.030 |
Why?
|
| Motor Cortex | 1 | 1994 | 65 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 977 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2020 | 1779 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 2090 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2013 | 1300 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 1993 | 26 | 0.020 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 209 | 0.020 |
Why?
|
| Ear, Middle | 1 | 2013 | 84 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 530 | 0.020 |
Why?
|
| Visual Cortex | 1 | 1994 | 84 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2013 | 53 | 0.020 |
Why?
|
| Remission Induction | 1 | 2014 | 307 | 0.020 |
Why?
|
| Total Lung Capacity | 1 | 2013 | 29 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2014 | 199 | 0.020 |
Why?
|
| Imidazoles | 1 | 2014 | 247 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2012 | 13 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2012 | 16 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 3904 | 0.020 |
Why?
|
| Lymphangiogenesis | 1 | 2012 | 27 | 0.020 |
Why?
|
| APACHE | 1 | 2013 | 68 | 0.020 |
Why?
|
| Skin | 2 | 2008 | 753 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 337 | 0.020 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 2012 | 20 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 266 | 0.020 |
Why?
|
| Glucuronidase | 1 | 2012 | 27 | 0.020 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2012 | 27 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2025 | 2382 | 0.020 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2012 | 3 | 0.020 |
Why?
|
| Endotoxins | 1 | 2013 | 217 | 0.020 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2012 | 12 | 0.020 |
Why?
|
| Intestinal Perforation | 1 | 2012 | 46 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1994 | 228 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 132 | 0.020 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2012 | 34 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2158 | 0.020 |
Why?
|
| Doxycycline | 1 | 2012 | 62 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 159 | 0.020 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2012 | 61 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2013 | 246 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 2524 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1581 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1707 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2017 | 517 | 0.020 |
Why?
|
| Feces | 1 | 2014 | 495 | 0.020 |
Why?
|
| Creatinine | 1 | 2013 | 515 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2012 | 204 | 0.020 |
Why?
|
| Emphysema | 1 | 2012 | 100 | 0.020 |
Why?
|
| Prostate | 1 | 2012 | 158 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 451 | 0.020 |
Why?
|
| Corticosterone | 1 | 2012 | 241 | 0.020 |
Why?
|
| Karnofsky Performance Status | 1 | 2010 | 37 | 0.020 |
Why?
|
| Pyrroles | 1 | 2012 | 220 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 142 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2014 | 728 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 971 | 0.020 |
Why?
|
| Synapses | 1 | 1994 | 439 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1990 | 18 | 0.020 |
Why?
|
| Magnetics | 1 | 1990 | 46 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 1993 | 473 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2014 | 716 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 167 | 0.020 |
Why?
|
| Streptococcaceae | 1 | 2009 | 2 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 451 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 283 | 0.020 |
Why?
|
| Pinocytosis | 1 | 2009 | 6 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2009 | 58 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1547 | 0.020 |
Why?
|
| Clinical Medicine | 1 | 2009 | 26 | 0.020 |
Why?
|
| CD11c Antigen | 1 | 2009 | 40 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 1100 | 0.020 |
Why?
|
| Energy Intake | 1 | 2012 | 512 | 0.020 |
Why?
|
| Chimera | 1 | 2008 | 61 | 0.020 |
Why?
|
| Myositis | 1 | 2009 | 57 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2014 | 933 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2008 | 41 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1990 | 174 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 782 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2009 | 105 | 0.020 |
Why?
|
| Lead | 1 | 2008 | 71 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2008 | 15 | 0.020 |
Why?
|
| Weight Gain | 1 | 2012 | 561 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1179 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2009 | 207 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1321 | 0.020 |
Why?
|
| Thymoma | 1 | 2008 | 37 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 2008 | 30 | 0.020 |
Why?
|
| Indoles | 1 | 2012 | 507 | 0.020 |
Why?
|
| Hemoptysis | 1 | 2008 | 35 | 0.020 |
Why?
|
| Renal Artery | 1 | 2008 | 43 | 0.020 |
Why?
|
| Pneumothorax | 1 | 2008 | 52 | 0.020 |
Why?
|
| Young Adult | 2 | 2018 | 14218 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 2007 | 79 | 0.020 |
Why?
|
| NADPH Oxidase 2 | 1 | 2007 | 32 | 0.020 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2007 | 46 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2008 | 288 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2865 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2007 | 102 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2007 | 70 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2010 | 17291 | 0.020 |
Why?
|
| Metalloporphyrins | 1 | 2007 | 63 | 0.020 |
Why?
|
| Food Parasitology | 1 | 2006 | 4 | 0.020 |
Why?
|
| Time | 1 | 2007 | 84 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 315 | 0.020 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2006 | 12 | 0.020 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2006 | 13 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2008 | 360 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2007 | 137 | 0.020 |
Why?
|
| Immunization | 1 | 2008 | 375 | 0.020 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2006 | 13 | 0.020 |
Why?
|
| Complement C1q | 1 | 2006 | 32 | 0.020 |
Why?
|
| Protein Prenylation | 1 | 2006 | 19 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2006 | 53 | 0.020 |
Why?
|
| CD36 Antigens | 1 | 2006 | 32 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2010 | 8333 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 202 | 0.010 |
Why?
|
| Leukemia, Plasma Cell | 1 | 2006 | 4 | 0.010 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2006 | 23 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 886 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2008 | 335 | 0.010 |
Why?
|
| Protein Phosphatase 1 | 1 | 2006 | 32 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 46 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 2028 | 0.010 |
Why?
|
| Pyridines | 1 | 2010 | 609 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2008 | 184 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2005 | 24 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 66 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 1990 | 409 | 0.010 |
Why?
|
| Lysophospholipids | 1 | 2006 | 80 | 0.010 |
Why?
|
| CD47 Antigen | 1 | 2005 | 42 | 0.010 |
Why?
|
| Acute Disease | 1 | 2008 | 1036 | 0.010 |
Why?
|
| Abdominal Pain | 1 | 2006 | 149 | 0.010 |
Why?
|
| Bacteremia | 1 | 2008 | 222 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 2008 | 332 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 234 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2012 | 11772 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2011 | 835 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 167 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 475 | 0.010 |
Why?
|
| Eosinophilia | 1 | 2006 | 223 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 1048 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 618 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 321 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2006 | 207 | 0.010 |
Why?
|
| Macaca fascicularis | 2 | 1994 | 70 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 1471 | 0.010 |
Why?
|
| Antioxidants | 1 | 2007 | 550 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2008 | 531 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5423 | 0.010 |
Why?
|
| Weight Loss | 1 | 2008 | 858 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 630 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7202 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 3542 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2000 | 4 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2000 | 39 | 0.010 |
Why?
|
| Mesencephalon | 1 | 2000 | 65 | 0.010 |
Why?
|
| Lymphokines | 1 | 2000 | 128 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 162 | 0.010 |
Why?
|
| Fibronectins | 1 | 2000 | 136 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2006 | 1164 | 0.010 |
Why?
|
| Tretinoin | 1 | 2000 | 125 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2000 | 154 | 0.010 |
Why?
|
| Neuroglia | 1 | 2000 | 173 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2000 | 179 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 6013 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 414 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1994 | 335 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1993 | 43 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1993 | 33 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 216 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1993 | 268 | 0.010 |
Why?
|
| Axons | 1 | 1993 | 204 | 0.010 |
Why?
|
| Latex | 1 | 1990 | 9 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 164 | 0.000 |
Why?
|
| Microspheres | 1 | 1990 | 142 | 0.000 |
Why?
|
| Transplantation, Autologous | 1 | 1990 | 300 | 0.000 |
Why?
|
| Leukemia | 1 | 1990 | 246 | 0.000 |
Why?
|
| Neoplasms | 1 | 1990 | 2906 | 0.000 |
Why?
|